Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history? (Q38162867)

30 August 2017

Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history? (English)

1 reference

30 August 2017

Marija Kalaba

1

1 reference

30 August 2017

Brian Godman

2

1 reference

30 August 2017

Aleksandar Vuksanović

3

1 reference

30 August 2017

Marion Bennie

4

1 reference

30 August 2017

Richard E Malmström

5

1 reference

30 August 2017

1 November 2012

1 reference

Journal of Comparative Effectiveness Research

30 August 2017

1 reference

30 August 2017

1

1 reference

30 August 2017

6

1 reference

30 August 2017

539-549

1 reference

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups

30 August 2017

1 reference

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

21 January 2018

1 reference

Policies to enhance prescribing efficiency in europe: findings and future implications

21 January 2018

1 reference

Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs

21 January 2018

1 reference

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment

21 January 2018

1 reference

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

21 January 2018

1 reference

Initiatives to enhance renin-angiotensin prescribing efficiency in Austria: impact and implications for other countries

21 January 2018

1 reference

Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future

21 January 2018

1 reference

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension

21 January 2018

1 reference

Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines

21 January 2018

1 reference

Focus on the ONTARGET results.

21 January 2018

1 reference

Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.

21 January 2018

1 reference

The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review

21 January 2018

1 reference

Potential savings without compromising the quality of care

21 January 2018

1 reference

Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on.

21 January 2018

1 reference

Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials

21 January 2018

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

Economic burden of cardiovascular diseases in the enlarged European Union

21 January 2018

1 reference

Different versions of the anatomical therapeutic chemical classification system and the defined daily dose--are drug utilisation data comparable?

21 January 2018

1 reference

Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database

21 January 2018

1 reference

Pharmaceutical policies in European countries in response to the global financial crisis.

21 January 2018

1 reference

Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK.

21 January 2018

1 reference

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

21 January 2018

1 reference

Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available

21 January 2018

1 reference

Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data

21 January 2018

1 reference

Fixed-dose combinations improve medication compliance: a meta-analysis.

21 January 2018

1 reference

Pay-for-performance programs in family practices in the United Kingdom

21 January 2018

1 reference

Enhancing the rational use of new medicines across European health care systems

21 January 2018

1 reference

The ‘Wise List’- A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

21 January 2018

1 reference

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

21 January 2018

1 reference

Quality Incentives: The Case Of U.K. General Practitioners

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/CER.12.62

1 reference

30 August 2017

1 reference